Evidence map›Paper›PMID 26850128›Full record

ReviewFungal genetics and biology : FG & B2016

Saccharomyces cerevisiae as a tool for mining, studying and engineering fungal polyketide synthases.

Carly Bond, Yi Tang, Li Li

Abstract readReview
In one paragraph

Review in Fungal genetics and biology : FG & B, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Characterization of a NRPS-like Protein fromJournal of fungi (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Transcriptional Activation of Biosynthetic Gene Clusters in Filamentous Fungi.Frontiers in bioengineering and biotechnology · 2022
    Review
  10. EngineeringJournal of fungi (Basel, Switzerland) · 2021
    Article
  11. Review
  12. Review
  13. Expression of fungal biosynthetic gene clusters inSynthetic and systems biotechnology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carly BondDepartment of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, United States.
Yi TangDepartment of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, United States; Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095, United States. Electronic address: yitang@ucla.edu.
Li LiDepartment of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, United States; Engineering Research Center of Industrial Microbiology (Ministry of Education), College of Life Sciences, Fujian Normal University, Fuzhou, Fujian 350108, China; State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University, Shanghai 200030, China.

Funding

Genomic and synthetic biology tools for expressing natural product gene clustersU01GM110706 · NIGMS · STANFORD UNIVERSITY · PI DAVIS, RONALD WAYNE, STEINMETZ, LARS M · 2014 to 2018
$10.9M
Rediscovering Natural Chemical Diversity -1DP1GM106413DP1GM106413 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TANG, YI · 2012 to 2016
$3.9M
Biotechnology Training in Biomedical Sciences and EngineeringT32GM067555 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GU, ZHEN · 2005 to 2019
$2.8M
Characterization and Engineering of Fungal Megasynthases in Escherichia coliR01GM085128 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TANG, YI · 2008 to 2016
$2.1M
NCCDPHP CDC HHS 5 DP1 GM106413NIGMS NIH HHS 1 U01 GM110706NIGMS NIH HHS 2 R01 GM085128NIGMS NIH HHS 2 T32 GM067555NIGMS NIH HHS DP1 GM106413NIGMS NIH HHS R01 GM085128NIGMS NIH HHS T32 GM067555NIGMS NIH HHS U01 GM110706
6 · The paper itself

Abstract

Small molecule secondary metabolites produced by organisms such as plants, bacteria, and fungi form a fascinating and important group of natural products, many of which have shown promise as medicines. Fungi in particular have been important sources of natural product polyketide pharmaceuticals. While the structural complexity of these polyketides makes them interesting and useful bioactive compounds, these same features also make them difficult and expensive to prepare and scale-up using synthetic methods. Currently, nearly all commercial polyketides are prepared through fermentation or semi-synthesis. However, elucidation and engineering of polyketide pathways in the native filamentous fungi hosts are often hampered due to a lack of established genetic tools and of understanding of the regulation of fungal secondary metabolisms. Saccharomyces cerevisiae has many advantages beneficial to the study and development of polyketide pathways from filamentous fungi due to its extensive genetic toolbox and well-studied metabolism. This review highlights the benefits S. cerevisiae provides as a tool for mining, studying, and engineering fungal polyketide synthases (PKSs), as well as notable insights this versatile tool has given us into the mechanisms and products of fungal PKSs.

Indexed as

Biological ProductsHomologous RecombinationMetabolic EngineeringMetabolic Networks and PathwaysPolyketidesPolyketide SynthasesSaccharomyces cerevisiaeBiological ProductsPolyketidesPolyketide SynthasesHeterologous hostMegasynthasesPolyketides

Identifiers

PMID26850128
PMCPMC4789138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.